VetUK Flea & Tick Treatment Plus for Cats 50 mg/60 mg Spot-on Solution (Fipronil and S-Methoprene)

Country: Ingilterra

Lingwa: Ingliż

Sors: VMD (Veterinary Medicines Directorate)

Ingredjent attiv:

(S)-Methoprene, Fipronil

Disponibbli minn:

EU Pharmaceuticals Ltd

Kodiċi ATC:

QP53AX65

INN (Isem Internazzjonali):

(S)-Methoprene, Fipronil

Għamla farmaċewtika:

Spot-on solution

Tip ta 'preskrizzjoni:

AVM-GSL - Authorised Veterinary Medicine – General Sales List

Grupp terapewtiku:

Cats

Żona terapewtika:

Ectoparasiticide

L-istatus ta 'awtorizzazzjoni:

Authorized

Data ta 'l-awtorizzazzjoni:

2018-08-08

Karatteristiċi tal-prodott

Unlimited Renewal: March 2023
AN: 03442/2022
Page 1 of 6
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
VetUK Flea & Tick Treatment Plus for Cats 50 mg/60 mg Spot-on Solution
(Fipronil
and S-Methoprene)
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each pipette of 0.5 ml contains:
ACTIVE SUBSTANCES:
Fipronil
50.00 mg
(S)-methoprene
60.00 mg
EXCIPIENTS:
Butylhydroxyanisole (E320)
0.10 mg
Butylhydroxytoluene (E321)
0.05 mg
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Spot-on solution.
Clear amber solution.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cats.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
- To be used against infestations with fleas, alone or in association
with ticks and/or
biting lice.
- Elimination of fleas (_Ctenocephalides _spp.). Insecticidal efficacy
against new
infestations with adult fleas persists for 4 weeks. Prevention of the
multiplication of
fleas by inhibiting the development of eggs (ovicidal activity),
larvae and pupae
(larvicidal activity) originating from eggs laid by adult fleas for
six weeks after
application.
- Elimination of ticks (_Ixodes ricinus_, _Dermacentor variabilis_,
_Rhipicephalus _
_sanguineus_). The product has a persistent acaricidal efficacy for up
to 2 weeks
against ticks (based on experimental data).
- Elimination of biting lice (_Felicola subrostratus_).
Unlimited Renewal: March 2023
AN: 03442/2022
Page 2 of 6
4.3
CONTRAINDICATIONS
In the absence of available data, the product should not be used on
kittens less than
8 weeks old and/or weighing less than 1 kg.
Do not use on sick (e.g. systemic diseases, fever) or convalescent
animals.
Do not use in rabbits due to a risk of adverse drug reactions or even
death.
In absence of studies, the use of the product is not recommended in
non-target
species.
Do not use in known cases of hypersensitivity to the active substances
or to any of
the excipients.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
Avoid contact with the animal’s eyes.
4.5
SPECIAL PRECAUTIONS